207 related articles for article (PubMed ID: 25959847)
41. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
[TBL] [Abstract][Full Text] [Related]
42. [Community-acquired bacteremia].
Cisterna R; Cabezas V; Gómez E; Busto C; Atutxa I; Ezpeleta C
Rev Esp Quimioter; 2001 Dec; 14(4):369-82. PubMed ID: 11856984
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and outcome of bacteraemia in neutropenic patients in a single institution from 1991-2012.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Rovira M; Esteve J; Mensa J
Epidemiol Infect; 2015 Mar; 143(4):734-40. PubMed ID: 24977667
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.
Cesana C; Nosari AM; Klersy C; Miqueleiz S; Rossi V; Ferrando P; Valentini M; Barbarano L; Morra E
Haematologica; 2003 Sep; 88(9):1022-8. PubMed ID: 12969810
[TBL] [Abstract][Full Text] [Related]
45. Blood culture contamination in a neonatal intensive care unit in Shiraz, Southwest-Central Iran.
Hashemizadeh Z; Bazargani A; Davarpanah MA
Med Princ Pract; 2011; 20(2):133-6. PubMed ID: 21252567
[TBL] [Abstract][Full Text] [Related]
46. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
[TBL] [Abstract][Full Text] [Related]
47. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
48. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
Mylotte JM; Kahler L; McCann C
Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
[TBL] [Abstract][Full Text] [Related]
49. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
Kuo CB; Lin JC; Peng MY; Wang NC; Chang FY
J Microbiol Immunol Infect; 2007 Aug; 40(4):317-24. PubMed ID: 17712466
[TBL] [Abstract][Full Text] [Related]
50. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
51. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia.
Vallés J; Palomar M; Alvárez-Lerma F; Rello J; Blanco A; Garnacho-Montero J; Martín-Loeches I;
Crit Care Med; 2013 Jan; 41(1):76-83. PubMed ID: 23222266
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
53. Staphylococcus aureus bacteremia without a localizing source in pediatric patients.
Ligon J; Kaplan SL; Hulten KG; Mason EO; McNeil JC
Pediatr Infect Dis J; 2014 May; 33(5):e132-4. PubMed ID: 24732394
[TBL] [Abstract][Full Text] [Related]
54. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia.
Lam SW; Bauer SR; Neuner EA
Int J Infect Dis; 2012 Jun; 16(6):e453-6. PubMed ID: 22497963
[TBL] [Abstract][Full Text] [Related]
55. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
[TBL] [Abstract][Full Text] [Related]
56. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
57. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
58. The prevalence of bacteraemia-related retinal lesions in seriously ill patients.
Celik I; Cihangiroglu M; Yilmaz T; Kohle U; Akbulut A
J Infect; 2006 Feb; 52(2):97-104. PubMed ID: 15904970
[TBL] [Abstract][Full Text] [Related]
59. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
